The effect of prenatal perfluorinated chemicals exposures on pediatric atopy

I-Jen Wang1, Wu-Shiun Hsieh, Chia-Yang Chen

  • 1Department of Pediatrics, Taipei Hospital, Department of Health, Taipei, Taiwan.

Insights

Prenatal exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) is linked to higher immunoglobulin E (IgE) levels in newborns. This association was observed specifically in male infants, suggesting a potential impact on immune development.

Area of Science:

  • Environmental Health
  • Immunology
  • Pediatrics

Background:

  • The impact of perfluorinated compounds (PFCs) on immune system development and allergic diseases remains unclear.
  • Prenatal exposure to environmental chemicals is a growing concern for child health.

Purpose of the Study:

  • To investigate the association between prenatal exposure to specific PFCs and immunoglobulin E (IgE) levels.
  • To examine the relationship between prenatal PFC exposure and the development of atopic dermatitis (AD) in early childhood.

Main Methods:

  • A cohort of newborns was assessed for cord blood PFC concentrations using Ultra-performance liquid chromatography/triple-quadrupole mass spectrometry (UPLC-MS/MS).
  • Infants were followed up to age 2 years for AD development and serum total IgE levels.
  • Statistical analyses explored correlations between cord blood PFCs, IgE levels, and AD incidence, with stratification by gender.

Main Results:

  • Elevated levels of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in cord blood were positively correlated with cord blood IgE levels.
  • This positive correlation between PFOA, PFOS, and IgE was significant in male infants.
  • No significant association was found between prenatal PFOS exposure and the development of atopic dermatitis.

Conclusions:

  • Prenatal exposure to PFOA and PFOS is associated with increased cord blood IgE levels, particularly in boys.
  • These findings suggest a potential role for specific PFCs in modulating fetal immune system development.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...